Liver/Biliary Disorders News

Increased levels of vitamin D may prevent nonalcoholic fatty liver disease among European populations, according to research published in Clinical Gastroenterology and Hepatology.

Patients with alcohol-associated cirrhosis had higher mortality following ICU discharge compared with patients with cirrhosis related to other causes, according to study results published in Mayo Clinic Proceedings.

Neoadjuvant immunotherapy Libtayo administered before surgical resection led to tumor necrosis in about one-third of patients with hepatocellular carcinoma, according to data published in The Lancet Gastroenterology and Hepatology.

Among patients newly diagnosed with hepatocellular carcinoma, there are significant racial and ethnic differences in barriers to care, according to survey results published in Clinical Gastroenterology and Hepatology.

Healio presents the following report on the top 10 hepatology peer-tested articles from 2021.

Biotechnology company COUR Pharmaceuticals announced that the FDA granted fast track designation to CNP-104, an investigational therapy for the treatment of primary biliary cholangitis, according to a company press release.

Many individuals look to the new year to follow through their resolutions such as diet and exercise and some are now attempting ‘Dry January’, to reset after a holiday full of drinking.

People with a parent, sibling or child with diabetes have increased risk for developing nonalcoholic fatty liver disease, or NAFLD, regardless of their own glucose status, according to study findings.

The ACG published guidelines for the preferred management of acute-on-chronic liver failure, which has emerged as a major cause of mortality worldwide, in the American Journal of Gastroenterology.

Maternal autoimmune hepatitis correlated with five-fold higher odds of preterm birth; however, cirrhosis did not impact these odds, according to study results.